Skip to main content

and
  1. No Access

    Article

    Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease

    Epstein–Barr virus (EBV) is an aetiologic risk factor for the development of multiple sclerosis (MS). However, the role of EBV-infected B cells in the immunopathology of MS is not well understood. Here we char...

    Samantha S. Soldan, Chenhe Su, Maria Chiara Monaco, Leena Yoon in Nature Microbiology (2024)

  2. Article

    Open Access

    Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection

    People living with HIV (PLWH) experience increased vulnerability to premature aging and inflammation-associated comorbidities, even when HIV replication is suppressed by antiretroviral therapy (ART). However, ...

    Leila B. Giron, Qin Liu, Opeyemi S. Adeniji, **angfan Yin in Nature Communications (2024)

  3. Article

    Open Access

    Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade

    Aberrant glycosylation is a crucial strategy employed by cancer cells to evade cellular immunity. However, it’s unclear whether homologous recombination (HR) status-dependent glycosylation can be therapeutical...

    Hao Nie, Pratima Saini, Taito Miyamoto, Li** Liao in Nature Communications (2024)

  4. Article

    Open Access

    Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging

    People living with HIV (PLWH), even when viral replication is controlled through antiretroviral therapy (ART), experience persistent inflammation. This inflammation is partly attributed to intestinal microbial...

    Shalini Singh, Leila B. Giron, Maliha W. Shaikh, Shivanjali Shankaran in Microbiome (2024)

  5. No Access

    Article

    Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer

    Acetate metabolism is an important metabolic pathway in many cancers and is controlled by acetyl-CoA synthetase 2 (ACSS2), an enzyme that catalyzes the conversion of acetate to acetyl-CoA. While the metabolic ...

    Katelyn D. Miller, Seamus O’Connor, Katherine A. Pniewski, Toshitha Kannan in Nature Cancer (2023)